Who owns EVOKE PHARMA INC COM NEW?
- Ticker: EVOK
- CUSIP Number: 30049g203
Tip: Access positions for across all investors
Analyze quarterly positions in Evoke Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evoke Pharma stock
Who bought or sold EVOKE PHARMA INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 847k | $516k | 100% | Mar 2024 |
|
| Altium Capital Management | 725k | $442k | 100% | Mar 2024 |
|
| Nantahala Capital Management | 675k | $412k | 100% | Mar 2024 |
|
| Vanguard Group | 30k | $18k | 0% | Mar 2024 |
|
| Geode Capital Management | 27k | $17k | 0% | Mar 2024 |
|
| Goldman Sachs Group | 14k | $8.2k | 100% | Mar 2024 |
|
| Millennium Management | 11k | $6.6k | 100% | Mar 2024 |
|
| Tower Research Capital | 7.4k | $4.5k | 28% | Mar 2024 |
|
| BlackRock | 1.5k | $893.040000 | -1% | Mar 2024 |
|
| UBS Group | 1.1k | $675.048600 | -62% | Mar 2024 |
|
| Morgan Stanley | 375.00 | $229.012500 | 100% | Mar 2024 |
|
| Goss Wealth Management | 208.00 | $127.004800 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 66.00 | $40.002600 | 154% | Mar 2024 |
|
| Royal Bank of Canada | 28.00 | $0 | 0% | Mar 2024 |
|